SS
GILD icon

Steve Schonfeld’s Gilead Sciences GILD Stock Holding History

Steve Schonfeld’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,000
Closed -$999K – 2235
2025
Q3 		$999K Buy
+9,000
New +$1.02M 0.01% 1369
2024
Q2 		– Sell
-100,000
Closed -$7.33M – 2306
2024
Q1 		$7.33M Buy
+100,000
New +$7.69M 0.05% 491

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steve Schonfeld's GILD Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Gilead Sciences (GILD) in Q2 2026: 57,030 shares worth $7.21M. The stake represents 0.03% of the portfolio and ranks #517 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in GILD as recently as Q3 2025.

Steve Schonfeld first reported a position in GILD in Q1 2016 and has held it in 34 quarters since. The position peaked at $53.4M in Q2 2024. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Steve Schonfeld held 57,030 shares of Gilead Sciences worth $7.21M as of Q2 2026.
  • Gilead Sciences was a new Steve Schonfeld position in Q2 2026.
  • Gilead Sciences made up 0.03% of Steve Schonfeld's portfolio in Q2 2026, its #517 holding.
  • Steve Schonfeld first reported a position in Gilead Sciences in Q1 2016 and has held it in 34 quarters since.
  • Steve Schonfeld's Gilead Sciences position peaked at $53.4M in Q2 2024.
  • 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.